These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33510207)

  • 21. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
    Salas S; Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Tranchand B; Monjanel-Mouterde S; Baciuchka-Palmaro M; Dupuis C; Yang C; Balti M; Lacarelle B; Duffaud F; Durand A; Favre R
    Ther Drug Monit; 2006 Aug; 28(4):532-9. PubMed ID: 16885721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure.
    de Jongh FE; Verweij J; Loos WJ; de Wit R; de Jonge MJ; Planting AS; Nooter K; Stoter G; Sparreboom A
    J Clin Oncol; 2001 Sep; 19(17):3733-9. PubMed ID: 11533095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
    Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
    Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy between body surface area and body composition in cancer.
    Stobäus N; Küpferling S; Lorenz ML; Norman K
    Nutr Cancer; 2013; 65(8):1151-6. PubMed ID: 24066882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
    Jastaniah W; Aseeri M
    J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body surface area as a determinant of pharmacokinetics and drug dosing.
    Sawyer M; Ratain MJ
    Invest New Drugs; 2001 May; 19(2):171-7. PubMed ID: 11392451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia.
    Kempf E; Hirsch P; Labopin M; Viguié F; Isnard F; Tang R; Marzac C; Marie JP; Mohty M; Legrand O
    Leuk Res; 2014 Dec; 38(12):1425-9. PubMed ID: 25443887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosing strategies for anticancer drugs: the good, the bad and body-surface area.
    Felici A; Verweij J; Sparreboom A
    Eur J Cancer; 2002 Sep; 38(13):1677-84. PubMed ID: 12175683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area.
    Kaestner SA; Sewell GJ
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):23-37. PubMed ID: 17305252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.
    Zhou Z; Rademaker AW; Gordon LI; LaCasce AS; Crosby-Thompson A; Vanderplas A; Abel GA; Rodriguez MA; Nademanee A; Kaminski MS; Czuczman MS; Millenson MM; Zelenetz AD; Niland J; Friedberg JW; Winter JN
    J Natl Compr Canc Netw; 2016 Oct; 14(10):1274-1281. PubMed ID: 27697981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
    Morrison VA; McCall L; Muss HB; Jatoi A; Cohen HJ; Cirrincione CT; Ligibel JA; Lafky JM; Hurria A
    J Geriatr Oncol; 2018 May; 9(3):228-234. PubMed ID: 29233548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values.
    Loos WJ; de Jongh FE; Sparreboom A; de Wit R; van Boven-van Zomeren DM; Stoter G; Nooter K; Verweij J
    J Clin Oncol; 2006 Apr; 24(10):1499-506. PubMed ID: 16574999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
    Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2016 May; 26(5):657-66. PubMed ID: 26959390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body surface area for adjustment of drug dose.
    Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of body mass index and body surface area on clinical outcomes after transcatheter aortic valve implantation.
    Arsalan M; Filardo G; Kim WK; Squiers JJ; Pollock B; Liebetrau C; Blumenstein J; Kempfert J; Van Linden A; Arsalan-Werner A; Hamm C; Mack MJ; Moellmann H; Walther T
    Clin Res Cardiol; 2016 Dec; 105(12):1042-1048. PubMed ID: 27535139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of normal tissue damage induced by cancer chemotherapy.
    Vriesendorp HM; Vriesendorp R; Vriesendorp FJ
    Cancer Chemother Pharmacol; 1987; 19(4):273-6. PubMed ID: 3297374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.
    Gurney HP; Ackland S; Gebski V; Farrell G
    J Clin Oncol; 1998 Jul; 16(7):2299-304. PubMed ID: 9667243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body surface area in normal-weight, overweight, and obese adults. A comparison study.
    Verbraecken J; Van de Heyning P; De Backer W; Van Gaal L
    Metabolism; 2006 Apr; 55(4):515-24. PubMed ID: 16546483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic.
    Sandy J; Della-Fiorentina S
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):365-72. PubMed ID: 23937317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and chemotherapy administration: between empiric and mathematic method review.
    Bouleftour W; Mery B; Chanal E; Rowinski E; Viard A; Forges F; Fournel P; Rivoirard R
    Acta Oncol; 2019 Jun; 58(6):880-887. PubMed ID: 30907190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.